Answers in CME at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Answers in CME takes part in 1 session at ASH 2026 in New Orleans. Its presence centres on continuing education in blood cancers, and it runs a symposium on four-drug treatment for newly diagnosed multiple myeloma. It also covers turning evidence into action for patients with polycythemia vera and essential thrombocythemia.
| Organization | ASH 2026 Attendance |
|---|---|
Accredited medical education company producing continuing education programs for clinicians. | Symposium Fri Dec 11 7:00pm–10:00pm From Evidence to Action in MPNs: Transforming Challenges to Opportunities in PV and ET Patients Treatment options for polycythemia vera and essential thrombocythemia after first-line therapy fails, including new targeted drugs for patients with unmet needs. Symposium Fri Dec 11 3:00pm–6:00pm Quadruplet Therapy in NDMM: Interpreting the Data, Applying the Evidence Tailoring four-drug frontline regimens for newly diagnosed myeloma using residual disease testing, transplant criteria, and new ways of giving treatment. |
Instantly find 20 buyers from Answers in CME
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction